The purpose of the company is the development, manufacture and distribution of organoid models based on human cells as well as integrated systems and solutions for the discovery, exploration and development of advanced therapies. The company may establish subsidiaries and branches and participate in other companies. The company may acquire, hold, encumber and dispose of real estate and intellectual property rights. The company may also carry out all commercial, financial and other activities that are directly or indirectly related to the purpose of the company. The company may grant loans and other direct or indirect financing to group companies and third parties, including its (direct and indirect) shareholders and their group companies, including within the framework of cash pooling agreements, and provide security of all kinds for their liabilities, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind, whether remunerated or not.